Clinical Trials Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Jan 7, 2022; 10(1): 166-176
Published online Jan 7, 2022. doi: 10.12998/wjcc.v10.i1.166
Figure 4
Figure 4  Histopathology and immunohistochemistry of localized lesions of chronic eczema to intralesional treatment with 5-FU+TA and TA before and 2 wk after treatment. (A) Representative histologic images of biopsy specimens from localized lesions of chronic eczema were collected before and at 2 wk after treatment. Tissue samples (n = 15 for each group) were stained with HE and antibodies against CD4, CD8, or CD103 to detect T-cell infiltration in the lesional skin. (B) CD4+, CD8+, and CD103+ T cell counts were quantified in high-power field images of lesions biopsied before and 2 wk after treatment. Blue points: 5-FU + TA group; Red points: TA group. aP < 0.05, bP < 0.01. 5-FU, 5-fluorouracil; TA, triamcinolone.